CD109 Antibody (B-9): sc-271039
- CD109 Antibody (B-9) is a mouse monoclonal IgG2a κ, cited in 1 publications, provided at 200 µg/ml
- raised against amino acids 957-1041 mapping within an internal region of CD109 of human origin
- recommended for detection of CD109 of human origin by WB, IP, IF and ELISA
- m-IgG Fc BP-HRP is the preferred secondary detection reagent for CD109 Antibody (B-9) for WB applications. This reagent is now offered in a bundle with CD109 Antibody (B-9) (see ordering information below).
QUICK LINKS
SEE ALSO...
CD109 Antibody (B-9) is a mouse monoclonal IgG2a antibody that detects CD109 in human samples through applications such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). CD109 is a glycosylphosphatidylinositol (GPI)-linked cell surface glycoprotein that plays a crucial role in various biological processes, particularly in the context of cancer. CD109 is a member of the α-Macroglobulin/C3, C4, C5 family of thioester-containing proteins and is notably expressed in CD34+ acute myeloid leukemia cell lines, activated T lymphoblasts, activated platelets, endothelial cells, and certain carcinomas, including lung and esophageal squamous cell types. CD109 exhibits characteristics of a cancer-testis antigen, which can be pivotal in cancer immunotherapy. Additionally, CD109 carries the platelet-specific Gov antigen system, which is essential for understanding complications related to platelet transfusions, such as transfusion refractoriness and neonatal alloimmune thrombocytopenia. Anti-CD109 antibody (B-9) effectively targets CD109, making this antibody a valuable tool for researchers investigating CD109′s role in hematological malignancies and other related conditions.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CD109 Antibody (B-9) | sc-271039 | 200 µg/ml | $322.00 | |||
CD109 Antibody (B-9): m-IgG Fc BP-HRP Bundle | sc-540196 | 200 µg Ab; 10 µg BP | $361.00 |